Torthaí cuardaigh - Reinaldo Franqui-Machin

  • 1 - 6 toradh as 6 á dtaispeáint
Beachtaigh na torthaí
  1. 1
    Role of NEK2A in Human Cancer and Its Therapeutic Potentials

    Role of NEK2A in Human Cancer and Its Therapeutic Potentials de réir Jiliang Xia, Reinaldo Franqui Machin, Zhimin Gu, Fenghuang Zhan

    Foilsithe / Cruthaithe 2015
    Faigh an téacs iomlán Faigh an téacs iomlán
    Revisão
    Cuir le mo chuid Ceanán
    Sábháilte in:
  2. 2
    Cancer stem cells are the cause of drug resistance in multiple myeloma: fact or fiction?

    Cancer stem cells are the cause of drug resistance in multiple myeloma: fact or fiction? de réir Reinaldo Franqui-Machin, Erik Wendlandt, Siegfried Janz, Fenghuang Zhan, Guido Tricot

    Foilsithe / Cruthaithe 2015
    Faigh an téacs iomlán Faigh an téacs iomlán
    Revisão
    Cuir le mo chuid Ceanán
    Sábháilte in:
  3. 3
    Destabilizing NEK2 overcomes resistance to proteasome inhibition in multiple myeloma

    Destabilizing NEK2 overcomes resistance to proteasome inhibition in multiple myeloma de réir Reinaldo Franqui-Machin, Mu Hao, Hua Bai, Zhimin Gu, Xin Zhan, Hasem Habelhah, Yogesh Jethava, Lugui Qiu, Ivana Frech, Guido Tricot, Fenghuang Zhan

    Foilsithe / Cruthaithe 2018
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  4. 4
    Alteration of mitochondrial biogenesis promotes disease progression in multiple myeloma

    Alteration of mitochondrial biogenesis promotes disease progression in multiple myeloma de réir Xin Zhan, Wenjie Yu, Reinaldo Franqui-Machin, Melissa L. Bates, Kalyan Nadiminti, Huojun Cao, Brad A. Amendt, Yogesh Jethava, Ivana Frech, Fenghuang Zhan, Guido Tricot

    Foilsithe / Cruthaithe 2017
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  5. 5
    TRIP13 modulates protein deubiquitination and accelerates tumor development and progression of B cell malignancies

    TRIP13 modulates protein deubiquitination and accelerates tumor development and progression of B cell malignancies de réir Can Li, Jiliang Xia, Reinaldo Franqui-Machin, Fangping Chen, Yanjuan He, Cody Ashby, Feixiang Teng, Hongwei Xu, Dingxiao Liu, Dongzheng Gai, Sadie Johnson, Frits van Rhee, Siegfried Janz, John D. Shaughnessy, Guido Tricot, Ivana Frech, Fenghuang Zhan

    Foilsithe / Cruthaithe 2021
    Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  6. 6
    Identification and Characterization of Tumor-Initiating Cells in Multiple Myeloma

    Identification and Characterization of Tumor-Initiating Cells in Multiple Myeloma de réir Minjie Gao, Hua Bai, Yogesh Jethava, Yujie Wu, Yuqi Zhu, Ye Yang, Jiliang Xia, Huojun Cao, Reinaldo Franqui-Machin, Kalyan Nadiminti, Gregory S. Thomas, Mohamed E. Salama, Peter Altevogt, Gail A. Bishop, Michael H. Tomasson, Siegfried Janz, Jumei Shi, Lijuan Chen, Ivana Frech, Guido Tricot, Fenghuang Zhan

    Foilsithe / Cruthaithe 2019
    Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:

Uirlisí cuardaigh: